Pharma news

Reset all filters
Geography
Company
Refine search
USFDA to modernise generic review with $37.6m funding
Americas
The US Food and Drug Administration is planning to use new budget funding to modernise generic drug review and promote more widespread use of generics.   19 June 2018
Senator proposes Hatch-Waxman change to boost generic development
Americas
US Senator Orrin Hatch has proposed an amendment to the Hatch-Waxman Act to “restore the careful balance” the act struck to incentivise generic drug development.   15 June 2018
Sage Therapeutics and Shionogi partner to develop antidepressant
Asia
US-based biopharmaceutical company Sage Therapeutics and Japan-based pharmaceutical corporation Shionogi have entered into a strategic collaboration to develop an antidepressant drug.   15 June 2018
Americas
The Patent Trial and Appeal Board has now rejected challenges to six patents owned by Gilead covering the company’s hepatitis C medicines.   14 June 2018
Pharma
The EU General Court today ruled on a pharmaceutical trademark dispute over the names ‘Emcur’ and ‘Emcure’, finding similarity for some goods and services but not others.   14 June 2018
Pharma
In order to maximise the value from the patent search process, IP practitioners should take note of several tips including offering clear guidance to the searcher—and even saying ‘thank you’. Ellen Sherin of GQ Life Sciences reports.   14 June 2018
Americas
Clinical technology company Medidata has bought Shyft Analytics, a cloud data analytics platform, for $195 million.   13 June 2018
Americas
China-based pharmaceutical technology company WuXi AppTec has partnered with artificial intelligence specialist Insilico Medicine to integrate Insilico’s AI technology with WuXi’s laboratory infrastructure.   13 June 2018
Americas
Drug makers Takeda and Lundbeck have filed a patent infringement lawsuit over anti-depressant medication Trintellix (vortioxetine hydrobromide), less than a month after launching similar claims.   12 June 2018
Americas
The US Federal Trade Commission has filed an amicus brief urging a district court to reject Takeda’s claim that its patent infringement lawsuit brought under the Hatch-Waxman Act cannot be a sham.   11 June 2018